Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors
Saveria Pastore, Daniela Lulli, Giampiero Girolomoni
Archives of Toxicology (2014) Vol. 88, Iss. 6, pp. 1189-1203
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Microneedle-Mediated Vaccination: Innovation and Translation
Tao Sheng, Bowen Luo, Wentao Zhang, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 113919-113919
Closed Access | Times Cited: 112
Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease
Helena M. Kok, Lucas L. Falke, Roel Goldschmeding, et al.
Nature Reviews Nephrology (2014) Vol. 10, Iss. 12, pp. 700-711
Closed Access | Times Cited: 152
Cancer: the dark side of wound healing
Gopinath M. Sundaram, Shan Quah, Prabha Sampath
FEBS Journal (2018) Vol. 285, Iss. 24, pp. 4516-4534
Open Access | Times Cited: 98
Dermatologic Adverse Events Following Afatinib in a Woman with Non-Small-Cell Lung Cancer: A Case Report
Laila Tsaqilah, Ananda Sintia Putri, Erda Avriyanti
Clinical Cosmetic and Investigational Dermatology (2025) Vol. Volume 18, pp. 151-159
Open Access | Times Cited: 1
Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment
Zhenguang Wang, Yelei Guo, Weidong Han
Protein & Cell (2017) Vol. 8, Iss. 12, pp. 896-925
Open Access | Times Cited: 65
Epidermal growth factor dampens pro-inflammatory gene expression induced by interferon-gamma in global transcriptome analysis of keratinocytes
David C. Gibbs, Myles R. McCrary, Carlos S. Moreno, et al.
BMC Genomics (2025) Vol. 26, Iss. 1
Open Access
PARP‐1 involves in UVB‐induced inflammatory response in keratinocytes and skin injury via regulation of ROS‐dependent EGFR transactivation and p38 signaling
Ling‐Ya Chiu, Nan‐Lin Wu, Chi‐Feng Hung, et al.
The FASEB Journal (2021) Vol. 35, Iss. 3
Open Access | Times Cited: 28
Best evidence summary for preventing and preventing epidermal growth factor receptor inhibitors induced paronychia in cancer patients
Kexuan Li, Xiuyue Qiu, Jiayu Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
Witold Owczarek, Monika Słowińska, Aleksandra Lesiak, et al.
Advances in Dermatology and Allergology (2017) Vol. 5, pp. 418-428
Open Access | Times Cited: 39
Epidermal growth factor receptor inhibitors trigger a type I interferon response in human skin
Daniela Lulli, Maria Luigia Carbone, Saveria Pastore
Oncotarget (2016) Vol. 7, Iss. 30, pp. 47777-47793
Open Access | Times Cited: 38
The MEK Inhibitors Trametinib and Cobimetinib Induce a Type I Interferon Response in Human Keratinocytes
Daniela Lulli, Maria Luigia Carbone, Saveria Pastore
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 10, pp. 2227-2227
Open Access | Times Cited: 34
Multi-target mechanism of Solanum xanthocarpum for treatment of psoriasis based on network pharmacology and molecular docking
Nilanchala Sahu, Swati Madan, Ramanpreet Walia, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 11, pp. 101788-101788
Open Access | Times Cited: 9
Passive targeting of phosphatiosomes increases rolipram delivery to the lungs for treatment of acute lung injury: An animal study
Chia-Lang Fang, Chih-Jen Wen, Ibrahim A. Aljuffali, et al.
Journal of Controlled Release (2015) Vol. 213, pp. 69-78
Closed Access | Times Cited: 30
Update review of skin adverse events during treatment of lung cancer and colorectal carcinoma with epidermal growth receptor factor inhibitors
Yanmei Peng, Qiang Li, Jingyi Zhang, et al.
BioScience Trends (2018) Vol. 12, Iss. 6, pp. 537-552
Open Access | Times Cited: 29
Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy
Carmine Pinto, Carlo Barone, Giampiero Girolomoni, et al.
American Journal of Clinical Oncology (2016) Vol. 39, Iss. 4, pp. 407-415
Closed Access | Times Cited: 28
Decoy receptor 3 is involved in epidermal keratinocyte commitment to terminal differentiation via EGFR and PKC activation
Nan‐Lin Wu, Duen-Yi Huang, Shie‐Liang Hsieh, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 4, pp. 542-551
Open Access | Times Cited: 14
Passive targeting of thermosensitive diblock copolymer micelles to the lungs: synthesis and characterization of poly(N-isopropylacrylamide)-block-poly(ε-caprolactone)
Ren‐Shen Lee, Chih-Hung Lin, Ibrahim A. Aljuffali, et al.
Journal of Nanobiotechnology (2015) Vol. 13, Iss. 1
Open Access | Times Cited: 28
Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities
Emily K. Kleczko, Lynn E. Heasley
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 27
Risk factors for medical adhesive-related skin injury at the site of peripherally inserted central venous catheter placement in patients with cancer: a single-centre prospective study from China
Mengying Qi, Yuju Qin, Si-ya Meng, et al.
BMJ Open (2024) Vol. 14, Iss. 3, pp. e080816-e080816
Open Access | Times Cited: 2
Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature
Christopher Iriarte, Jennifer Yeh, Allireza Alloo, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 9
Closed Access | Times Cited: 2
Identification of Beilschmiedia tsangii Root Extract as a Liver Cancer Cell–Normal Keratinocyte Dual-Selective NRF2 Regulator
Yi‐Siao Chen, Hsun‐Shuo Chang, Hui‐Hua Hsiao, et al.
Antioxidants (2021) Vol. 10, Iss. 4, pp. 544-544
Open Access | Times Cited: 17
Cetuximab and panitumumab in a patient with colon cancer and concomitant chronic skin disease: A potential beneficial effect on psoriasis vulgaris
Ken Okamoto
World Journal of Gastroenterology (2015) Vol. 21, Iss. 12, pp. 3746-3746
Open Access | Times Cited: 20
Association between serum ligands and the skin toxicity of anti‐epidermal growth factor receptor antibody in metastatic colorectal cancer
Naoki Takahashi, Yasuhide Yamada, Koh Furuta, et al.
Cancer Science (2015) Vol. 106, Iss. 5, pp. 604-610
Open Access | Times Cited: 16
Linking tyrosine kinase inhibitor-mediated inflammation with normal epithelial cell homeostasis and tumor therapeutic responses
Natalia J. Gurule, Lynn E. Heasley
Cancer Drug Resistance (2018)
Open Access | Times Cited: 16
Retrospective Analysis of Skin Toxicity in Patients under Anti-EGFR Tyrosine Kinase Inhibitors: Our Experience in Lung Cancer
Maria Carmela Annunziata, Maria Ferrillo, Eleonora Cinelli, et al.
Open Access Macedonian Journal of Medical Sciences (2019) Vol. 7, Iss. 6, pp. 973-977
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top